Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Autoreactive T cells induce necrosis and not BCL-2-regulated or death receptor-mediated apoptosis or RIPK3-dependent necroptosis of transplanted islets in a mouse model of type 1 diabetesZhao, Yuxing ; Scott, Nicholas A. ; Fynch, Stacey ; Elkerbout, Lorraine ; Wong, W. Wei-Lynn ; Mason, Kylie D. ; Strasser, Andreas ; Huang, David C. ; Kay, Thomas W. H. ; Thomas, Helen E.Diabetologia, 2015-01, Vol.58 (1), p.140-148 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
2 |
Material Type: Artigo
|
Understanding and preventing type 1 diabetes through the unique working model of TrialNetBattaglia, Manuela ; Anderson, Mark S. ; Buckner, Jane H. ; Geyer, Susan M. ; Gottlieb, Peter A. ; Kay, Thomas W. H. ; Lernmark, Åke ; Muller, Sarah ; Pugliese, Alberto ; Roep, Bart O. ; Greenbaum, Carla J. ; Peakman, MarkDiabetologia, 2017-11, Vol.60 (11), p.2139-2147 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
3 |
Material Type: Artigo
|
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD miceAkazawa, Satoru ; Mackin, Leanne ; Jhala, Gaurang ; Fynch, Stacey ; Catterall, Tara ; Selck, Claudia ; Graham, Kate L. ; Krishnamurthy, Balasubramanian ; Pappas, Evan G. ; Kwong, Chun-Ting J. ; Sutherland, Andrew P. R. ; Kay, Thomas W. H. ; Brodnicki, Thomas C. ; Thomas, Helen E.Diabetologia, 2021-04, Vol.64 (4), p.878-889 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
4 |
Material Type: Artigo
|
Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)-study protocol for a phase 2, randomized, placebo controlled trialWaibel, M ; Thomas, H E ; Wentworth, J M ; Couper, J J ; MacIsaac, R J ; Cameron, F J ; So, M ; Krishnamurthy, B ; Doyle, M C ; Kay, T WCurrent controlled trials in cardiovascular medicine, 2022-05, Vol.23 (1), p.433-433, Article 433 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |